# OnCo record irecist (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/irecist/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "irecist" ;
  schema:name "iRECIST (response criteria for immunotherapy trials)"@en ;
  schema:alternateName "iRECIST"@en, "iUPD"@en, "iCPD"@en, "unconfirmed progressive disease"@en, "confirmed progressive disease"@en ;
  schema:description "iRECIST is the version of the scan-measuring rules used in immunotherapy trials, where a tumour can look bigger before it shrinks, so apparent growth must be confirmed on a later scan before it counts as progression."@en ;
  schema:url <https://onco.cc/terms/irecist/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(17)30074-8>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC5648544/> ;
  onco:related <https://onco.cc/terms/recist/>, <https://onco.cc/terms/progressive-disease/>, <https://onco.cc/terms/irrc/>, <https://onco.cc/terms/imrecist/>, <https://onco.cc/terms/itrecist/> ;
  onco:technologies <https://onco.cc/technologies/ct/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/checkpoint-inhibitor/> .